Overview

Angiotensin Receptor Blockers in Aortic Stenosis

Status:
Recruiting
Trial end date:
2025-02-01
Target enrollment:
Participant gender:
Summary
This study is intended to investigate the effect of angiotensin receptor blockers (ARBs) on mild-to-moderate aortic stenosis.
Phase:
Phase 4
Details
Lead Sponsor:
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Collaborator:
Odense University Hospital
Treatments:
Angiotensin Receptor Antagonists